APC and colorectal carcinoma: In the majority of CRC patients, this hyperactivation is caused by either inactivating APC mutations or activating mutations in the β-catenin gene CTNNB1, both resulting in constitutive activation of the Wnt/β-catenin pathway, independent of Wnt ligand binding.